LeadIQ logo
Learn more at LeadIQ.com

Insights

Partnering Opportunities Recent collaborations with Foundation Medicine and Novo Holdings indicate a focus on advancing treatment options and attracting substantial investments. Leveraging these partnerships can lead to mutually beneficial business alliances in the biotechnology sector.

Technology Adoption Merus N.V.'s tech stack includes widely used platforms like Akamai, Drupal, and Google Cloud, showcasing a commitment to innovation. Positioning tech solutions as complementary to their services can drive sales by emphasizing efficiency and cutting-edge capabilities.

Executive Talent Acquisition Hiring Dr. Fabian Zohren as the Chief Medical Officer signifies a strategic move to strengthen leadership in cancer treatment drugs. Leveraging Dr. Zohren's expertise and network can open doors to potential collaborations and sales by highlighting Merus's strong leadership team.

Financial Backing Securing significant funding of $400M combined with a revenue range of $50-100M showcases financial stability and growth potential. Highlighting this financial strength can instill confidence in potential partners, investors, and clients, creating more sales opportunities.

Clinical Trials & Expertise With several candidate drugs in clinical trials and a focus on developing bispecific antibody therapies, Merus N.V. demonstrates expertise in cancer treatment. Emphasizing successful trial outcomes and therapeutic advancements can attract pharmaceutical companies and healthcare institutions, leading to potential sales of their innovative therapies.

Similar companies to Merus N.V.

Merus N.V. Tech Stack

Merus N.V. uses 8 technology products and services including Akamai, Drupal, MySQL, and more. Explore Merus N.V.'s tech stack below.

  • Akamai
    Content Delivery Network
  • Drupal
    Content Management System
  • MySQL
    Database
  • Google Cloud
    Infrastructure As A Service
  • web-vitals
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Akamai Bot Manager
    Security
  • YouTube
    Video Players

Media & News

Merus N.V.'s Email Address Formats

Merus N.V. uses at least 1 format(s):
Merus N.V. Email FormatsExamplePercentage
F.Last@merus.nlJ.Doe@merus.nl
70%
First.Last@merus.nlJohn.Doe@merus.nl
16%
First_Last@merus.nlJohn_Doe@merus.nl
14%

Frequently Asked Questions

Where is Merus N.V.'s headquarters located?

Minus sign iconPlus sign icon
Merus N.V.'s main headquarters is located at Yalelaan 62 Utrecht, Utrecht 3584 CM NL. The company has employees across 2 continents, including EuropeNorth America.

What is Merus N.V.'s phone number?

Minus sign iconPlus sign icon
You can contact Merus N.V.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Merus N.V.'s stock symbol?

Minus sign iconPlus sign icon
Merus N.V. is a publicly traded company; the company's stock symbol is MRUS.

What is Merus N.V.'s official website and social media links?

Minus sign iconPlus sign icon
Merus N.V.'s official website is merus.nl and has social profiles on LinkedIn.

How much revenue does Merus N.V. generate?

Minus sign iconPlus sign icon
As of October 2024, Merus N.V.'s annual revenue reached $75M.

What is Merus N.V.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Merus N.V.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Merus N.V. have currently?

Minus sign iconPlus sign icon
As of October 2024, Merus N.V. has approximately 257 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: J. T.Chief Scientific Officer: C. G.Chief Medical Officer: A. J.. Explore Merus N.V.'s employee directory with LeadIQ.

What industry does Merus N.V. belong to?

Minus sign iconPlus sign icon
Merus N.V. operates in the Biotechnology Research industry.

What technology does Merus N.V. use?

Minus sign iconPlus sign icon
Merus N.V.'s tech stack includes AkamaiDrupalMySQLGoogle Cloudweb-vitalsjQueryAkamai Bot ManagerYouTube.

What is Merus N.V.'s email format?

Minus sign iconPlus sign icon
Merus N.V.'s email format typically follows the pattern of . Find more Merus N.V. email formats with LeadIQ.

How much funding has Merus N.V. raised to date?

Minus sign iconPlus sign icon
As of October 2024, Merus N.V. has raised $400M in funding. The last funding round occurred on May 29, 2024 for $400M.
Merus N.V.

Merus N.V.

Biotechnology ResearchUtrecht, Netherlands201-500 Employees

Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.

Working at Merus offers opportunity to grow and develop a career that offers both individual and company success. You have the chance to make an impact within the oncology field by being part of the development of bispecific antibody therapies (Biclonics®) to help fight cancer. Merus’ Head Quarters are located in The Netherlands, with offices in the US and collaborators around the world. As of 2016 we are listed on NASDAQ and over a period of 10 years we have several candidate drugs in clinical trials. For more information, please visit www.merus.nl
Read our Community Guidelines: https://merus.nl/community-guidelines/ 

Section iconCompany Overview

Headquarters
Yalelaan 62 Utrecht, Utrecht 3584 CM NL
Phone number
Website
merus.nl
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MRUS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconFunding & Financials

  • $400M

    Merus N.V. has raised a total of $400M of funding over 11 rounds. Their latest funding round was raised on May 29, 2024 in the amount of $400M.

  • $50M$100M

    Merus N.V.'s revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $400M

    Merus N.V. has raised a total of $400M of funding over 11 rounds. Their latest funding round was raised on May 29, 2024 in the amount of $400M.

  • $50M$100M

    Merus N.V.'s revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.